Sadly, some of the strongest characters that stand out in the books didn't make it into any of the Harry Potter movies.
H.C. Wainwright analyst Andrew Fein raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $35 from $30 and keeps a Buy rating on ...
It's important to remember the ongoing controversial statements by the creator of the Harry Potter franchise. CBR supports ...
The microfinance sector faces mounting challenges as gross NPAs nearly doubled in H1, signaling deep stress in asset quality. India's markets ended the week on a sharp downturn, with the Sensex and ...
Max Healthcare stock is in an overall uptrend and has given a range breakout at its all-time high zones. Traders can buy for a target of Rs 1250 in the next 2-3 weeks,” Shivangi Sarda, Analyst, ...
This film by Sally Aitken follows a hummingbird rescue center and the woman who tends to its denizens with immense care. By Alissa Wilkinson Lean, fast and furious action movies may look simple on ...
Submission of warning letter received from NSE with regard to corporate announcements submitted in letter head of the Company where-in PAN of the Company was mentioned. Intimation of loss of Share ...